Challenges in developing therapies in fragile X syndrome: how the FXLEARN trial can guide research
Journal of Clinical Investigation - Cardiology
MARCH 1, 2024
Unfortunately, despite treatment of young children with combined pharmacological and learning interventions for a prolonged period, no efficacy of blocking mGluR activity was observed.
Let's personalize your content